Mon-Fri 9:00-18:00 CET+39 095 7211344info@vitasanlabs.com

Family · Pharmaceutical analytical standards

Mesalazine

5-aminosalicylic acid, an anti-inflammatory that acts directly on the lining of the gut: in 1977 it was recognised as the active part of sulfasalazine and it is now a mainstay of ulcerative colitis treatment. This family brings together the active ingredient, pharmacopoeial impurities, metabolites, labelled standards and other impurities.

Did you know?Sulfasalazine, its parent drug, was developed between the late 1930s and the early 1940s by Nanna Svartz, Sweden's first female professor of medicine, with rheumatoid arthritis in mind.

MesalazineGo to the active ingredient →
MesalazineActive ingredientMesalazineCat. No. P-M063-001CAS 89-57-6
4-AminophenolPharmacopoeial impurity4-AminophenolCat. No. P-M063-002CAS 123-30-8
Mesalamine-d3Isotopically labelledMesalamine-d3Cat. No. P-M063-023CAS 1309283-32-6

EDQM standards 4

The official European Pharmacopoeia standards for this family.

Reference substanceMesalazine CRSEDQM code Y0000297Family Mesalazine

Need a molecule you cannot find?

Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.